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Effects of Adjunctive Transferrin on Susceptibility and Emergence of 
Resistance in Gram-negative Pathogens
Time kill assays were done using ciprofloxacin or meropenem 
with and without transferrin. Viability was assessed at 1, 2, 4, 
6, 8, and 24 hours for A. baumannii and at 1, 4, and 24 hours 
for K. pneumonia. The assay was done using either resazurin 
(cellular metabolic readout) or quantitative culturing. 
Antibiotic resistant mutants were selected by passaging a high 
inoculum of bacteria in sub-lethal concentrations of antibiotic 
for 24 hours or by serial passaging lower inocula of bacteria for 
20 days with or without rh-transferrin. Phagocytosis assay with 
murine macrophages for different bacterial strains after 
antibiotic exposure with or without transferrin was done. 
C3HeB/FeJ mice were infected IV and a sub-therapeutic dose 
of ciprofloxacin (3 mg/kg BID) with and without transferrin 
(100 mg/kg) was administered. Mice survival was assessed 
over 7 days.
The high speed of antibiotic resistance formation in nosocomial 
bacteria together with overuse of antibiotics have promoted the 
current multi-drug resistance crisis. We attempted to decrease 
the emergence of resistant mutants using a novel combination 
of antibiotics with recombinant human transferrin (rh-
transferrin). We hypothesized that rh-transferrin, which 
functions by passively starving the bacteria of iron needed for 
microbial replication [1], would exert less selective pressure as 
compared to traditional antibiotics. It has been reported in 
previous studies that transferrin has broad antimicrobial 
effects in vitro against Gram-positive and Gram-negative 
bacteria and fungal pathogens [2]. 
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Project goal
The time-kill assays for both bacterial species showed mostly 
no interaction between the antibiotics and rh-transferrin in 
vitro for most strains. Mostly bacteriostatic mode of action 
defined for transferrin. Mutant selection: for both 24 hours and 
20 days passage experiment, more antibiotic resistant mutants 
were selected for when bacteria were cultured in antibiotic 
alone vs antibiotic + transferrin. Culturing A.baumannii AB074 
in cipro for 15 days leads to increased virulence based on 
macrophage phagocytosis assay. Transferrin prevents high 
virulence formation. LD100 for all strains in C3HeB/FeJ mice 
were defined.  In vivo efficacy experiments will begin soon with 
combination therapy.
We found that transferrin containing therapeutic regimens 
suppressed the emergence of resistance in vitro, and is 
promising as an adjunct to antibiotic therapy.Study the in vitro and in vivo effect of adjunctive transferrin on 
susceptibility and emergence of resistance in the Gram-
negative pathogens Acinetobacter baumannii and Klebsiella 
pneumoniae.
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